Neopharma today has 6 state-of-the-art manufacturing sites (API & Finished Dose) globally. We have ensured world-class quality in design, equipment and operations in all our manufacturing facilities across the world. With the first manufacturing facility started in UAE, Neopharma now has units in USA, Brazil, India, Japan along with additional units in UAE. Our units ensure that we are able to provide best-in-class products to patients across 50 countries worldwide.
Our manufacturing operations are focused on producing generics, branded generics, specialty, over-the-counter (OTC) products, oncology.
Neopharma’s commitment to quality and state of the art manufacturing facilities base has led to manufacturing partnerships with major global pharmaceutical companies such as Pfizer, Merck, GSK, Lagap, Abbott among many others.